NCT06586983Active, not recruiting
Decentralization of Hepatitis B Care in Sub-Saharan Africa: a Pilot Program in Ethiopia
Source: ClinicalTrials.gov · Last updated 20 Oct 2026
Brief summary (registry, in English)
The goal of this observational study is to study models of care for decentralized hepatitis B treatment in Ethiopia. Three different models of decentralized HBV care (standard model, simplified model, test-and-treat model) will be implemented at primary hospitals or health clinics in Ethiopia. Treatment will be given for free to patients who meet the treatment criteria. We will compare clinical outcome, laboratory outcomes and programmatic outcome measures between the 3 models.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 4500 (estimated)
- First submitted
- 4 Sept 2024
- Start date
- 4 Sept 2024
- Primary completion date
- 5 Sept 2028
- Lead sponsor
- Oslo University Hospital
- Diseases
- Hepatitis B
- NCT number
- NCT06586983
What you commit to
- Study type: Observational
- Planned participants: 4500
- From 4 Sept 2024 to the primary completion date, 5 Sept 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Other disease with short life expectancy (disseminated cancer etc.)
Age
- Below 18 years of age.
Other
- Negative HBsAg rapid test at screening visit.
Who the study is looking for
- Adult (at least 18 years of age) who is HBsAg positive.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Addis Ababa University Coordinator of this site? Confirm its status | Addis Ababa | Ethiopia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.